| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $1,000,000 ) |
| 2024 | 2024 | LUCEOME BIOTECHNOLOGIES LLC | 1665 E 18TH ST | TUCSON | AZ | 85719-6808 | PIMA | USA | R44AI145502 | Enabling Toxoplasma gondii Kinome Directed Drug Discovery | 000 | 3 | NIH | 2/20/2024 | $1,000,000 |
| 2024 | 2021 | LUCEOME BIOTECHNOLOGIES LLC | 1665 E 18TH ST | TUCSON | AZ | 85719-6808 | PIMA | USA | R44AI150237 | Kinase Targeted Antimalarial Agents | 000 | 2 | NIH | 10/23/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,000,000 ) |
| 2023 | 2023 | LUCEOME BIOTECHNOLOGIES LLC | 1665 E 18TH ST | TUCSON | AZ | 85719-6808 | PIMA | USA | R44AI145502 | Enabling Toxoplasma gondii Kinome Directed Drug Discovery | 000 | 2 | NIH | 2/27/2023 | $1,000,000 |
|
| Issue Date FY: 2022 ( Subtotal = $240,429 ) |
| 2022 | 2022 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R43GM146510 | Split-luciferase Epigenetic Assays for Drug Discovery | 000 | 1 | NIH | 3/24/2022 | $240,429 |
|
| Issue Date FY: 2021 ( Subtotal = $798,586 ) |
| 2021 | 2021 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R44AI150237 | Kinase Targeted Antimalarial Agents | 000 | 2 | NIH | 11/5/2020 | $798,586 |
| 2021 | 2019 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R43AI145502 | Enabling Toxoplasma gondii Kinome Directed Drug Discovery | 000 | 1 | NIH | 9/10/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $957,654 ) |
| 2020 | 2020 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R44AI150237 | Kinase Targeted Antimalarial Agents | 000 | 1 | NIH | 12/13/2019 | $957,654 |
| 2020 | 2018 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R44TR001916 | Tools for Accelerating R&D for Historically Understudied Protein Kinases | 000 | 2 | NIH | 9/13/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $225,000 ) |
| 2019 | 2019 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R43AI145502 | Enabling Toxoplasma gondii Kinome Directed Drug Discovery | 000 | 1 | NIH | 3/11/2019 | $225,000 |
| 2019 | 2017 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R44GM109740 | Kinome-wide Cell-Based Assays | 000 | 3 | NIH | 4/24/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $699,809 ) |
| 2018 | 2018 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R44TR001916 | Tools for Accelerating R&D for Historically Understudied Protein Kinases | 000 | 2 | NIH | 1/15/2018 | $699,809 |
| 2018 | 2014 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R43GM109726 | Rapid Histone Methyltransferase Profiling with Luminescent Reporters | 000 | 1 | NIH | 9/17/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,331,290 ) |
| 2017 | 2017 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R44GM109740 | Kinome-wide Cell-Based Assays | 000 | 3 | NIH | 12/14/2016 | $622,659 |
| 2017 | 2017 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R44TR001916 | Tools for Accelerating R&D for Historically Understudied Protein Kinases | 000 | 1 | NIH | 2/1/2017 | $708,631 |
| 2017 | 2014 | LUCEOME BIOTECHNOLOGIES, L.L.C. | 1665 E. 18TH STREET, SUITE 106 | TUCSON | AZ | 85719-6808 | PIMA | USA | R43GM110911 | Enabling Malarial Kinome Directed Drug Discovery | 000 | 1 | NIH | 11/9/2016 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $873,704 ) |
| 2016 | 2016 | LUCEOME BIOTECHNOLOGIES LLC | 3938 EAST GRANT ROAD | TUCSON | AZ | 85712 | PIMA | USA | R44GM109740 | Kinome-wide Cell-Based Assays | 000 | 2 | NIH | 1/13/2016 | $873,704 |
| 2016 | 2014 | LUCEOME BIOTECHNOLOGIES LLC | 3938 EAST GRANT ROAD | TUCSON | AZ | 85712 | PIMA | USA | R43GM109740 | Kinome-wide cell-based assays | 000 | 1 | NIH | 1/8/2016 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $738,735 ) |
| 2014 | 2014 | LUCEOME BIOTECHNOLOGIES LLC | 3938 EAST GRANT ROAD | TUCSON | AZ | 85712 | PIMA | USA | R43GM109740 | Kinome-wide cell-based assays | 000 | 1 | NIH | 8/26/2014 | $239,923 |
| 2014 | 2014 | LUCEOME BIOTECHNOLOGIES LLC | 3938 EAST GRANT ROAD | TUCSON | AZ | 85712 | PIMA | USA | R43GM109726 | Rapid Histone Methyltransferase Profiling with Luminescent Reporters | 000 | 1 | NIH | 2/19/2014 | $274,561 |
| 2014 | 2014 | LUCEOME BIOTECHNOLOGIES LLC | 3938 EAST GRANT ROAD | TUCSON | AZ | 85712 | PIMA | USA | R43GM110911 | Enabling Malarial Kinome Directed Drug Discovery | 000 | 1 | NIH | 7/14/2014 | $224,251 |
|
| Issue Date FY: 2012 ( Subtotal = $787,730 ) |
| 2012 | 2012 | LUCEOME BIOTECHNOLOGIES LLC | 3938 EAST GRANT ROAD | TUCSON | AZ | 85712 | PIMA | USA | R44GM087807 | RAPID KINASE PROFILING WITH LUMINESCENT REPORTERS | 000 | 3 | NIH | 7/16/2012 | $787,730 |
|
| Issue Date FY: 2011 ( Subtotal = $1,205,348 ) |
| 2011 | 2011 | LUCEOME BIOTECHNOLOGIES LLC | 3938 EAST GRANT ROAD | TUCSON | AZ | 85712 | PIMA | USA | R44GM087807 | RAPID KINASE PROFILING WITH LUMINESCENT REPORTERS | 000 | 2 | NIH | 7/29/2011 | $917,931 |
| 2011 | 2011 | LUCEOME BIOTECHNOLOGIES LLC | 3938 EAST GRANT ROAD | TUCSON | AZ | 85712 | PIMA | USA | R43GM096538 | A POLY(ADP-RIBOSE) DETECTION ASSAY ENABLING DRUG DISCOVERY AND DEVELOPMENT | 000 | 1 | NIH | 4/26/2011 | $287,417 |
|
| Issue Date FY: 2010 ( Subtotal = $45,000 ) |
| 2010 | 2010 | LUCEOME BIOTECHNOLOGIES LLC | 3938 EAST GRANT ROAD | TUCSON | AZ | 85712 | PIMA | USA | R43GM087807 | RAPID KINASE PROFILING WITH LUMINESCENT REPORTERS | 000 | 1 | NIH | 1/22/2010 | $45,000 |
|
| Issue Date FY: 2009 ( Subtotal = $135,886 ) |
| 2009 | 2009 | LUCEOME BIOTECHNOLOGIES LLC | 3938 EAST GRANT ROAD | TUCSON | AZ | 85712 | PIMA | USA | R43GM087807 | RAPID KINASE PROFILING WITH LUMINESCENT REPORTERS | 000 | 1 | NIH | 8/10/2009 | $135,886 |
|
|